Industry

First and Only NIR Vein Visualization Device Featuring This Advanced Technology MEDFORD, N.Y.–(BUSINESS WIRE)–AccuVein Inc., the global leader in Near Infrared (NIR) vein visualization, announced today that it will be showcasing its innovative vein visualization device, the AccuVein® AV500, which features its patented “True Center™” technology during this year’s Association for Vascular Access (AVA2022) Annual … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Meningococcal Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The global meningococcal vaccines market size reached US$ 3.0 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 5.1 Billion by 2027, exhibiting a CAGR of 9.25% during 2021-2027. … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Tissue Diagnostics Market by Product (Antibodies, Kits, Slide Staining System, Tissue Processing System), Technology (ISH, IHC, Special Staining), Disease (Breast Cancer, NSCLC, Lymphoma), End User (Hospitals, Research Laboratories) – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The global Tissue Diagnostics market is growing at a CAGR of 6.6% during … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Analytical Instrument Qualification and System Validation” training has been added to ResearchAndMarkets.com’s offering. This 2-day course guides attendees through equipment qualification, calibration and computer system validation processes from planning to reporting. It also explains regulatory requirements in these areas, including EU and US GMPs, as well as data integrity guidance documents from national … [Read more…]

OMLONTI® is the 2nd FDA-approved product from Santen in the last 15 months for patients in the U.S. with vision conditions EMERYVILLE, Calif. & UBE, Japan–(BUSINESS WIRE)–Santen Inc., the U.S. subsidiary of Santen Pharmaceutical Co., Ltd. (Santen), and UBE Corporation (UBE) today announced that the U.S. Food and Drug Administration (FDA) has approved OMLONTI® (omidenepag … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Peripheral Neuropathy Treatment Market, by Indication, by Treatment and Non-Pharmacological Therapies, by End-user, and by Region – Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering. Peripheral neuropathy is a disorder of the peripheral nerves. These nerves send messages between the central nervous system, the brain … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Blood Pressure Monitoring Devices Market, By Product Type, By Technology, By End User, By Region, Competition Forecast & Opportunities, 2027” report has been added to ResearchAndMarkets.com’s offering. The global blood pressure monitoring devices market is expected to grow at a promising rate in the forecast period, 2023-2027. The increasing geriatric population worldwide … [Read more…]

Company secures over 90,000 square feet of workspace, offering a more immersive and collaborative experience for its workforce MISSISSAUGA, Ontario–(BUSINESS WIRE)–PointClickCare Technologies, a leading healthcare technology platform enabling meaningful collaboration and access to real‐time insights, today announced expansion of its Canadian headquarters to The Well. Located in one of Toronto’s most vibrant neighborhoods, the space … [Read more…]

With more than 35,000 combinations tested, IDT delivers unique master mix with proprietary blend to enrich endpoint fluorescence, optimize data confidence CORALVILLE, Iowa–(BUSINESS WIRE)–#1StepMasterMix–To support the growing need for an inhibitor resistant, high-performance master mix that allows for direct amplification of crude samples, Integrated DNA Technologies has launched the PrimeTime™ 1-Step 4X Broad-Range qPCR Master … [Read more…]

The Association of Latino Professionals For America Recognizes the Most Powerful Latinas in Business, Technology, Healthcare, and Non-Profit Sectors BRISBANE, Calif.–(BUSINESS WIRE)–CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that Dr. Grace Colón, a … [Read more…]